Latest Breaking News On - Longboard pharmaceuticals - Page 26 : comparemela.com

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

Megane knightLongboard pharmaceuticals incExchange commissionLongboard pharmaceuticalsCantor virtual brain weekInvestors relationsPrivate securities litigation reform actInvestor relations

Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023

Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Megane knightLongboard pharmaceuticals incExchange commissionCantor virtual brain weekInvestors relationsPrivate securities litigation reform actInvestor relationsLongboard pharmaceuticals

Longboard Pharmaceuticals, Inc (NASDAQ:LBPH) Sees Significant Increase in Short Interest

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Rating) was the target of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 202,400 shares, a growth of 149.9% from the May 15th total of 81,000 shares. Approximately 1.4% of the company’s shares are sold short. Based […]

Longboard pharmaceuticalsBlackrock incHealth asset managementNews ratings for longboard pharmaceuticals dailyLongboard pharmaceuticals incBourgeon capital managementLongboard pharmaceuticals price performanceLongboard pharmaceuticals company profileCantor fitzgeraldHedge funds weigh in on longboard pharmaceuticalsAsset management incGet ratingCapital managementManagement incProsight managementLongboard pharmaceuticals daily

Short Interest in Longboard Pharmaceuticals, Inc (NASDAQ:LBPH) Increases By 149 9%

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Rating) was the recipient of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 202,400 shares, an increase of 149.9% from the May 15th total of 81,000 shares. Based on an average daily volume of 90,000 shares, the […]

Bourgeon capital managementCantor fitzgeraldHealth asset managementLongboard pharmaceuticals incAsset management incLongboard pharmaceuticals stock downInstitutional investors weigh in on longboard pharmaceuticalsBlackrock incLongboard pharmaceuticals company profileNews ratings for longboard pharmaceuticals dailyLongboard pharmaceuticalsGet ratingCapital managementManagement incProsight managementPharmaceuticals stock down

DelveInsight Business Research, LLP: CDKL5 Deficiency Disorder Market to Witness Upsurge in Growth, Assesses DelveInsight | Key Companies in the Market - Jazz, Stoke, Epygenix, Zogenix, UCB Pharma, Takeda, Eisai, Longboard, Marinus

The dynamics of the CDKL5 deficiency disorder market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the diseases

Mecklenburg vorpommernVincerx pharmaSumitomo dainippon pharmaKronos bioShruti thakurGenor pharmaStefan klotterNuvation bioPrnewswire delveinsightMarinus pharmaceuticalsCyclacel pharmaceuticalsZogenix incLongboard pharmaceuticalsInternational foundationJazz pharmaceuticalsDeficiency disorder companies